Unit AP707 Clinical Aesthetic Procedures: Botulinum Toxin Injections for the Face Assignment Brief

Qualification	Qualifi Level 7 Diploma in Clinical Aesthetic Practice (610/7007/5) Qualifi Level 7 Certificate in Clinical Aesthetic Procedures: Botulinum Toxin Injections (610/7010/5)
Unit Reference Number	Y/651/9196
Unit Code	AP707
Unit Title	Clinical Aesthetic Procedures: Botulinum Toxin Injections for the Face
RQF Level :	7
Number of Credits	15
Total Qualification Time (TQT)	150 hours
Guided Learning Hours (GLH)	75 hours

Learning Outcomes, and Assessment Criteria

Learning Outcomes. To achieve this unit a learner must be able to:		Assessment Criteria. Assessment of these outcomes demonstrates a learner can:		NOS/KSBs
LO1	Adhere to legal, ethical and professional standards for botulinum toxin procedures	1.1	Obtain and discuss the client’s consultation outcomes and prescription for the botulinum toxin type A procedure from the regulated independent prescriber to include: • legal, regulatory and organisational requirements • client procedure plan and areas to be treated • advice, support and guidance • emergency plan • medicine management policy • pain management strategy	PC1, PC2 KU1, KU2, KU3 KU18 KU19
		1.2	Describe the types, composition and pharmacological effects of chemical compounds in botulinum toxin solutions to include:  how religion and belief can prohibit a botulinum toxin type A procedure	KU6
		1.3	Explain the physiological effect botulinum toxin type A solution has on the targeted and surrounding facial muscle structures to include: • adaptation of injection techniques • adaptation of depth and placement	KU7
		1.5	Explain the purpose, use and limitations of botulinum toxin type A procedures in relation to: • past and current medical history • previous non-surgical cosmetic and/or dental procedure history • relevant lifestyle factors • contraindicated medication and medical conditions • the client’s physical and psychological suitability for the non-surgical cosmetic procedure • client expectations	KU8
		1.6	Explain t he regulatory and legislative requirements for prescription-only medicines to include licensed and offlabel product use	KU12
		1.7	Explain the licensed indicated use of prescription-only medicines and when and why they can be used off-label considering: • safety • treatment area • suitability • agreement with the regulated independent prescriber	KU13
		1.8	Explain the legislative requirements and restrictions for sourcing, storing and using licensed topical anaesthetics	KU15
		1.9	Describe the health and safety responsibilities in line with legislation before, during and after the botulinum toxin type A procedure	KU16
		1.10	Explain the legislative and indemnity requirements for gaining signed, informed consent for the elective nonsurgical cosmetic procedure manual examination of the skin magnifying light	KU25
		1.11	Explain the legislative, insurance and organisational requirements for taking and storing visual media of the client’s treatment area	KU30
		1.12	Explain the legislative and regulatory requirements for completing and storing the client’s medical and nonsurgical cosmetic procedure records	KU31
LO2	Conduct a client consultation and develop a personalised procedure plan for botulinum toxin procedures	2.1	Conduct a structured face-to-face client consultation, ensuring compliance with health and safety before, during, and after the botulinum toxin type A procedure, and effectively use visual aids to explain anticipated physical effects	PC3 KU17, KU21, KU32
		2.2	Discuss client objectives, concerns, expectations and desired outcomes to inform the botulinum toxin type A procedure plan including; fee structure, treatment options, and alternative treatment options	PC4 KU20, KU22
		2.3	Establish the botulinum toxin type A procedure plan in accordance with legislative requirements and organisational policies and procedures	PC5
		2.4	Reiterate, confirm and agree with the client that they have understood the proposed botulinum toxin type A procedure and pain management to including: • contra-actions • adverse reactions	PC6 KU9, KU11
		2.5	Obtain and review the client’s written informed consent for the botulinum toxin type A procedure and pain management, allowing an adequate time scale for the client to make an informed choice digital skin scanner	PC7, PC8 KU14, KU23, KU24
		2.6	Obtain the fulfilled prescription from the pharmacist with the client’s informed consent to include: • patient-specific direction • saline reconstitution solutions • device and needle type • storage instructions • waste disposal protocol	PC9
LO3	Deliver botulinum toxin procedures safely and effectively	3.1	Select an effective hygiene preparation product to meet the client’s needs in accordance with the manufacturer’s instructions	PC10, KU26
		3.2	Prepare the client’s treatment area in line with botulinum toxin type A protocol and risk management strategies, including marking the procedure sites where applicable	PC11
		3.3	Inject the botulinum toxin type A solution with a sterile, single-use needle following the botulinum toxin type A procedure protocol to include: • adaptation of injection techniques, depth and placement • in accordance with the preprocedure markings if applicable	PC12, KU27
		3.4	Monitor the client’s health, wellbeing and skin response throughout the botulinum toxin type A procedure, ensuring compliance with legislative requirements and organisational policies and procedures	PC13 KU28
		3.5	In the event of an adverse reaction or incident, the aesthetic practitioner must take prompt corrective action following the emergency plan to include:  promptly obtain medical intervention from the designated healthcare professional when complications arise and	PC14 KU9, KU10, KU29
			prescription-only medicine is required
		3.6	Conclude the procedure in line with the botulinum toxin type A protocol, legislative requirements and organisational procedures to include:  removing any pre-procedure markings if applicable	PC15
		3.7	Capture and securely store clientapproved images of the procedure area in compliance with insurance and organisation requirements	PC16
		3.8	Complete the client’s non-surgical cosmetic procedure records and store in line with data legislation	PC17
LO4	Provide aftercare for botulinum toxin procedures and review procedure outcomes	4.1	Provide verbal and written instructions and confirm the client’s receipt of pre and post-procedure advice to include: • the regulated independent prescriber’s contact details • emergency plan • contingency plan in the event of absence	PC19 KU36
		4.2	Discuss the outcomes and agree future procedures with the client	PC21
		4.3	Discuss, evaluate and record the outcomes with the regulated independent prescriber and agree further action and future procedures	PC20 KU34, KU35
LO5	Reflect on practice and engage in continuing professional development	5.1	Keep a reflective journal, review the botulinum toxin procedure and evaluate own strengths and areas for improvement	PC18, KU33
LO5		5.2	Explain the importance in engaging in, and documenting continuous professional development including keeping updated on policies, procedures and best practice guidance	KU4

Need Help With Your AP707 Clinical Aesthetic Procedures (Y/651/9196) Assignment?

Order Non Plagiarized Assignment

Many students find the AP707 Clinical Aesthetic Procedures assignment difficult because it involves legal requirements, client consultation, pharmacology, injection protocols, aftercare, and reflective practice all in one detailed assessment. Some also struggle with professional terminology, treatment planning, and linking theory with safe clinical practice. But now you do not need to worry because Students Assignment Help provides custom-written and plagiarism-free healthcare assignment help based on your exact qualification requirements. You can also explore our assignment samples to better understand reflective journals, procedure planning, and clinical documentation. Order trusted help with assignment today and receive fully human-written academic support delivered before your deadline.

Answer

University	Qualifi Ltd
Subject	AP707 Clinical Aesthetic Procedures: Botulinum Toxin Injections for the Face (Y/651/9196)

AP707 Clinical Aesthetic Procedures: Botulinum Toxin Injections for the Face (Y/651/9196) Assignment Brief 2026

Unit AP707 Clinical Aesthetic Procedures: Botulinum Toxin Injections for the Face Assignment Brief

Learning Outcomes, and Assessment Criteria